What Is Talazoparib?
Talazoparib is an oral prescription cancer medication that is used primarily in two conditions:
Metastatic Breast Cancer:
-
Talazoparib is used in adult patients with metastatic breast cancer that is HER2-negative (Human Epidermal Growth Factor Receptor 2-negative) and has an inherited BRCA (breast cancer gene) gene mutation.
-
Inherited BRCA gene mutations disrupt the body's natural ability to repair damaged DNA (deoxyribonucleic acid), allowing cancer cells to survive and proliferate.
-
Patients require a genetic test to determine whether they qualify for Talazoparib.
Advanced Prostate Cancer:
-
Talazoparib is approved for the treatment of high-risk advanced (mCRPC) prostate cancer in adult patients who no longer respond to hormone therapy and have developed DNA repair gene mutations.
-
In this situation, Talazoparib is used in conjunction with Enzalutamide to increase the patient's ability to control their cancer.
As such, Talazoparib is a targeted therapy that targets specific biological features within cancer cells.
How Talazoparib Works?
-
Talazoparib belongs to a class of drugs called PARP (poly (ADP-ribose) polymerase) inhibitors. PARP inhibitors, such as Talazoparib, are a group of drugs that are used to stop cancer cells from repairing damaged DNA. Understanding how Talazoparib works helps to explain its effectiveness with some types of genetic cancers.
-
Inside cells, PARP is a protein that helps fix damaged DNA. Damage to DNA occurs during regular cell division and due to exposure to daily environmental contaminants. Cells can repair any damage that is present and function normally.
-
Cancer cells with BRCA or similar DNA-repair defects rely heavily on PARP to survive. The process of cell division and exposure to daily environmental factors regularly result in DNA damage. DNA damage can usually be repaired, so normal cellular functioning can continue.
-
Talazoparib blocks PARP, so the cancer cells cannot repair their DNA, which leads to their death. Since BRCA pathways do not function in these cells, they must use other repair mechanisms to survive. Talazoparib inhibits PARP activity, preventing DNA repair and making it impossible.
-
In simple terms, it prevents cancer cells from repairing themselves, so they break down and stop growing, which is the core of Talazoparib's mechanism of action.
Who Can Take Talazoparib?
Talazoparib is used for treating:
-
Adults with HER2-negative and BRCA-mutated breast cancer who have had testing for the mutation.
-
Adults with advanced prostate cancer, but only when this is related to other mutations associated with DNA repair (repairing cells), or with Enzalutamide (a medication used to kill cancer cells).
-
Children cannot use this product. Its safety and effectiveness have not been established in children; therefore, its use in children is not recommended.
-
Based on genetics, type of cancer, and the individual's health, your physician will evaluate and make a decision if Talazoparib is appropriate.
Talazoparib Dosing
-
Breast Cancer:
Patients typically take Talazoparib by mouth at a dose of 1 mg (milligrams) once daily, either on an empty stomach or with food. Patients continue to take Talazoparib daily until the cancer worsens or the side effects of Talazoparib become intolerable.
-
Prostate Cancer:
When Talazoparib is given with Enzalutamide (an oral medication for prostate cancer), patients are typically asked to start with Talazoparib at a reduced dosage of approximately 0.5 mg taken orally daily.
If you have any renal impairment, your doctor may decrease your daily Talazoparib dosage further. Please see your oncologist to establish a dosage; do not adjust it yourself without consulting your doctor first.
Talazoparib Benefits and Efficacy
-
Talazoparib is a chemotherapeutic agent used to treat cancer, which has been demonstrated to be effective in slowing the progression of cancers in patients with breast tumours whose DNA repair genes (BRCA) were mutated.
-
In clinical trials in breast cancer, patients who received Talazoparib had longer disease-free survival than patients who received standard chemotherapy, despite receiving similar numbers of chemotherapy treatments.
-
Results have shown that when Talazoparib is taken with Enzalutamide, overall patient outcomes are much better than with Enzalutamide alone.
-
Many patients taking Talazoparib have had a longer period of time for their cancer not to progress, or they have had a much less aggressive disease for a longer period of time.
Side Effects and Safety Considerations
Common Side Effects:
Most of the Talazoparib side effects happen in the majority of patients taking this medicine. The reason is that this medication affects how blood cells are produced and how the body metabolizes food. Symptoms include:
-
Fatigue or feeling weak.
-
Decreased production of blood cells, which includes both red and white blood cells and platelets.
-
Nausea or vomiting and diarrhea.
-
Headaches.
-
Thinning hair or baldness.
-
Loss of appetite.
-
Possible changes to blood sugar and liver tests.
These are the side effects that your doctor will monitor most closely.
Serious Risks:
The following adverse effects are rare; however, they are considered very serious in nature:
-
Bone Marrow Disorders and Acute Leukemia:
These are rare medical complications, but when problematic, they can become very serious problems.
-
Low Blood Counts:
When your blood count levels become too low, this will put you at risk for developing infections, excessive bleeding, and extreme fatigue.
-
Birth Defects:
Women who are pregnant or planning to become pregnant, or their partner, needs to utilize effective birth control methods while taking Talazoparib, as outlined in Talazoparib prescribing information, and for an unspecified time after stopping treatment with Talazoparib.
Your physician may choose to withhold your medication or reduce the amount of medication you are taking, or counsel you to discontinue use of the drug altogether if the side effects are deemed unacceptable, following Talazoparib FDA safety guidance.
Conclusion
Talazoparib is a type of targeted therapy for cancer, specifically for patients with certain genetic abnormalities or changes. Talazoparib works to slow down the progression of the disease by preventing cancer from repairing itself. Talazoparib can be an effective treatment option when used under the supervision of a physician and regular monitoring. You can consult a cancer specialist for better clarity.
Key Takeaways
-
Talazoparib is a medication for the treatment of certain breast and prostate cancers that targets only those cancers.
-
Talazoparib acts by inhibiting the ability of cancer cells to repair their damaged DNA.
-
Patients who take Talazoparib should be closely monitored for any possible side effects related to blood, as these can occur.
